Avsana Labs

Avsana Labs

Biotechnology, 800 W Campbell Rd, Dallas, Texas, 75080, United States, 1-10 Employees

avsana.com

  • LinkedIn

phone no Phone Number: +19*********

Who is AVSANA LABS

Avsana Labs, formed September 30, 2020, is a biotechnology startup and spin-out company from the University of Texas at Dallas (UT Dallas) that seeks to improve viral diagnostic testing a...

Read More

map
  • 800 W Campbell Rd, Dallas, Texas, 75080, United States Headquarters: 800 W Campbell Rd, Dallas, Texas, 75080, United States
  • 2020 Date Founded: 2020
  • 1-10 Employees: 1-10
  • dollar-icon Revenue: $1 Billion and Over
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Biotechnology

SIC SIC Code: 5999; 8221 | NAICS Code: 721310 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from AVSANA LABS

Avsana Labs Org Chart and Mapping

Employees

Nadine Van Zyl

Vice President Operations

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Avsana Labs

Answer: Avsana Labs's headquarters are located at 800 W Campbell Rd, Dallas, Texas, 75080, United States

Answer: Avsana Labs's phone number is +19*********

Answer: Avsana Labs's official website is https://avsana.com

Answer: Avsana Labs's revenue is $1 Billion and Over

Answer: Avsana Labs's SIC: 5999; 8221

Answer: Avsana Labs's NAICS: 721310

Answer: Avsana Labs has 1-10 employees

Answer: Avsana Labs is in Biotechnology

Answer: Avsana Labs contact info: Phone number: +19********* Website: https://avsana.com

Answer: Avsana Labs, formed September 30, 2020, is a biotechnology startup and spin-out company from the University of Texas at Dallas (UT Dallas) that seeks to improve viral diagnostic testing and environmental viral monitoring using a cutting edge digital nanobubble methodology. The company aims to follow an accelerated path in bringing the technology to market, in collaboration with UT Dallas and the University of Texas Southwestern Medical School. By leveraging the technology being developed under an R01 NIAID grant to UT Dallas, Avsana intends to enable a significant societal benefit by helping to mitigate the spread of contagious viral infections, while ultimately helping to reduce the loss of life caused by both current and future pandemics. The aim is to develop a significantly improved testing capability, in terms of speed, accuracy, and cost-effectiveness, for both existing and future viruses.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access